Skip to content

Niox Article No: 02-1000

by Aerocrine AB De Novo

Active United States

De Novo DEN030001

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Post-NSE NumberDEN030001 Date30 Apr 2003DecidedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

De Novo

De Novo Number
FDA Product Code
MXA
Device Class
Class II
Regulation
21 CFR Part 862.3080
Advisory Committee
Clinical Toxicology
FDA Decision
DENG De Novo granted

Other devices from Aerocrine AB